DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (NYSE Amex: AXK) announced that Accelr8 and Novartis have extended their program agreement through September 30, 2011. Having reviewed new data, Novartis will now install a system in their own facility to expand development capacity. While this project proceeds, the companies will continue to negotiate and intend to agree upon business terms for a formal business relationship and definitive Business Agreement by September 30, 2011. The agreement also includes an option for Novartis to further extend project support through January 2, 2012.
